The global Therapeutic Protein market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Protein in various end use industries. The expanding demands from the Pharmaceutical Companies, Healthcare Service Providers, Research Organizations and Academic Research Institutes, are propelling Therapeutic Protein market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythropoietin segment is estimated at % CAGR for the next seven-year period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Therapeutic Protein market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Therapeutic Protein market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Protein sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Therapeutic Protein covered in this report include Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly and GeneScience Pharmaceuticals, etc.

The global Therapeutic Protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Amgen

Abbott Laboratories

AstraZeneca

Baxter International

Boehringer Ingelheim

Chugai Pharmaceutical

Diasome Pharmaceuticals

Eli Lilly

GeneScience Pharmaceuticals

Generex Biotechnology

Genentech

Scope of Therapeutic Protein - Market Report

Report Metric	Details
Report Name	Therapeutic Protein - Market
CAGR	5%
Global Therapeutic Protein market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Protein market, Segment by Type:	Monoclonal Antibodies Erythropoietin Insulin Interferon Human Growth Hormone Follicle Stimulating Hormone Blood Clotting Factors
Global Therapeutic Protein market, by Application	Pharmaceutical Companies Healthcare Service Providers Research Organizations Academic Research Institutes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Therapeutic Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Therapeutic Protein - Market report?

Ans: The Applications covered in the Therapeutic Protein - Market report are Pharmaceutical Companies, Healthcare Service Providers, Research Organizations, Academic Research Institutes

What are the Type segmentation covered in the Therapeutic Protein - Market report?

Ans: The Types covered in the Therapeutic Protein - Market report are Monoclonal Antibodies, Erythropoietin, Insulin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone, Blood Clotting Factors

1 Therapeutic Protein Market Overview

1.1 Therapeutic Protein Product Overview

1.2 Therapeutic Protein Market Segment by Type

1.2.1 Monoclonal Antibodies

1.2.2 Erythropoietin

1.2.3 Insulin

1.2.4 Interferon

1.2.5 Human Growth Hormone

1.2.6 Follicle Stimulating Hormone

1.2.7 Blood Clotting Factors

1.3 Global Therapeutic Protein Market Size by Type

1.3.1 Global Therapeutic Protein Market Size Overview by Type (2018-2029)

1.3.2 Global Therapeutic Protein Historic Market Size Review by Type (2018-2023)

1.3.3 Global Therapeutic Protein Forecasted Market Size by Type (2024-2029)

1.4 Key Regions Market Size Segment by Type

1.4.1 North America Therapeutic Protein Sales Breakdown by Type (2018-2023)

1.4.2 Europe Therapeutic Protein Sales Breakdown by Type (2018-2023)

1.4.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Type (2018-2023)

1.4.4 Latin America Therapeutic Protein Sales Breakdown by Type (2018-2023)

1.4.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Type (2018-2023)

2 Global Therapeutic Protein Market Competition by Company

2.1 Global Top Players by Therapeutic Protein Sales (2018-2023)

2.2 Global Top Players by Therapeutic Protein Revenue (2018-2023)

2.3 Global Top Players by Therapeutic Protein Price (2018-2023)

2.4 Global Top Manufacturers Therapeutic Protein Manufacturing Base Distribution, Sales Area, Product Type

2.5 Therapeutic Protein Market Competitive Situation and Trends

2.5.1 Therapeutic Protein Market Concentration Rate (2018-2023)

2.5.2 Global 5 and 10 Largest Manufacturers by Therapeutic Protein Sales and Revenue in 2022

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Protein as of 2022)

2.7 Date of Key Manufacturers Enter into Therapeutic Protein Market

2.8 Key Manufacturers Therapeutic Protein Product Offered

2.9 Mergers & Acquisitions, Expansion

3 Therapeutic Protein Status and Outlook by Region

3.1 Global Therapeutic Protein Market Size and CAGR by Region: 2018 VS 2022 VS 2029

3.2 Global Therapeutic Protein Historic Market Size by Region

3.2.1 Global Therapeutic Protein Sales in Volume by Region (2018-2023)

3.2.2 Global Therapeutic Protein Sales in Value by Region (2018-2023)

3.2.3 Global Therapeutic Protein Sales (Volume & Value) Price and Gross Margin (2018-2023)

3.3 Global Therapeutic Protein Forecasted Market Size by Region

3.3.1 Global Therapeutic Protein Sales in Volume by Region (2024-2029)

3.3.2 Global Therapeutic Protein Sales in Value by Region (2024-2029)

3.3.3 Global Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2024-2029)

4 Global Therapeutic Protein by Application

4.1 Therapeutic Protein Market Segment by Application

4.1.1 Pharmaceutical Companies

4.1.2 Healthcare Service Providers

4.1.3 Research Organizations

4.1.4 Academic Research Institutes

4.2 Global Therapeutic Protein Market Size by Application

4.2.1 Global Therapeutic Protein Market Size Overview by Application (2018-2029)

4.2.2 Global Therapeutic Protein Historic Market Size Review by Application (2018-2023)

4.2.3 Global Therapeutic Protein Forecasted Market Size by Application (2024-2029)

4.3 Key Regions Market Size Segment by Application

4.3.1 North America Therapeutic Protein Sales Breakdown by Application (2018-2023)

4.3.2 Europe Therapeutic Protein Sales Breakdown by Application (2018-2023)

4.3.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Application (2018-2023)

4.3.4 Latin America Therapeutic Protein Sales Breakdown by Application (2018-2023)

4.3.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Application (2018-2023)

5 North America Therapeutic Protein by Country

5.1 North America Therapeutic Protein Historic Market Size by Country

5.1.1 North America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

5.1.2 North America Therapeutic Protein Sales in Volume by Country (2018-2023)

5.1.3 North America Therapeutic Protein Sales in Value by Country (2018-2023)

5.2 North America Therapeutic Protein Forecasted Market Size by Country

5.2.1 North America Therapeutic Protein Sales in Volume by Country (2024-2029)

5.2.2 North America Therapeutic Protein Sales in Value by Country (2024-2029)

6 Europe Therapeutic Protein by Country

6.1 Europe Therapeutic Protein Historic Market Size by Country

6.1.1 Europe Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

6.1.2 Europe Therapeutic Protein Sales in Volume by Country (2018-2023)

6.1.3 Europe Therapeutic Protein Sales in Value by Country (2018-2023)

6.2 Europe Therapeutic Protein Forecasted Market Size by Country

6.2.1 Europe Therapeutic Protein Sales in Volume by Country (2024-2029)

6.2.2 Europe Therapeutic Protein Sales in Value by Country (2024-2029)

7 Asia-Pacific Therapeutic Protein by Region

7.1 Asia-Pacific Therapeutic Protein Historic Market Size by Region

7.1.1 Asia-Pacific Therapeutic Protein Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029

7.1.2 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2018-2023)

7.1.3 Asia-Pacific Therapeutic Protein Sales in Value by Region (2018-2023)

7.2 Asia-Pacific Therapeutic Protein Forecasted Market Size by Region

7.2.1 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2024-2029)

7.2.2 Asia-Pacific Therapeutic Protein Sales in Value by Region (2024-2029)

8 Latin America Therapeutic Protein by Country

8.1 Latin America Therapeutic Protein Historic Market Size by Country

8.1.1 Latin America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

8.1.2 Latin America Therapeutic Protein Sales in Volume by Country (2018-2023)

8.1.3 Latin America Therapeutic Protein Sales in Value by Country (2018-2023)

8.2 Latin America Therapeutic Protein Forecasted Market Size by Country

8.2.1 Latin America Therapeutic Protein Sales in Volume by Country (2024-2029)

8.2.2 Latin America Therapeutic Protein Sales in Value by Country (2024-2029)

9 Middle East and Africa Therapeutic Protein by Country

9.1 Middle East and Africa Therapeutic Protein Historic Market Size by Country

9.1.1 Middle East and Africa Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029

9.1.2 Middle East and Africa Therapeutic Protein Sales in Volume by Country (2018-2023)

9.1.3 Middle East and Africa Therapeutic Protein Sales in Value by Country (2018-2023)

9.2 Middle East and Africa Therapeutic Protein Forecasted Market Size by Country

9.2.1 Middle East and Africa Therapeutic Protein Sales in Volume by Country (2024-2029)

9.2.2 Middle East and Africa Therapeutic Protein Sales in Value by Country (2024-2029)

10 Company Profiles

10.1 Amgen

10.1.1 Amgen Company Information

10.1.2 Amgen Introduction and Business Overview

10.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Amgen Therapeutic Protein Products Offered

10.1.5 Amgen Recent Development

10.2 Abbott Laboratories

10.2.1 Abbott Laboratories Company Information

10.2.2 Abbott Laboratories Introduction and Business Overview

10.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Abbott Laboratories Therapeutic Protein Products Offered

10.2.5 Abbott Laboratories Recent Development

10.3 AstraZeneca

10.3.1 AstraZeneca Company Information

10.3.2 AstraZeneca Introduction and Business Overview

10.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.3.4 AstraZeneca Therapeutic Protein Products Offered

10.3.5 AstraZeneca Recent Development

10.4 Baxter International

10.4.1 Baxter International Company Information

10.4.2 Baxter International Introduction and Business Overview

10.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Baxter International Therapeutic Protein Products Offered

10.4.5 Baxter International Recent Development

10.5 Boehringer Ingelheim

10.5.1 Boehringer Ingelheim Company Information

10.5.2 Boehringer Ingelheim Introduction and Business Overview

10.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Boehringer Ingelheim Therapeutic Protein Products Offered

10.5.5 Boehringer Ingelheim Recent Development

10.6 Chugai Pharmaceutical

10.6.1 Chugai Pharmaceutical Company Information

10.6.2 Chugai Pharmaceutical Introduction and Business Overview

10.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Chugai Pharmaceutical Therapeutic Protein Products Offered

10.6.5 Chugai Pharmaceutical Recent Development

10.7 Diasome Pharmaceuticals

10.7.1 Diasome Pharmaceuticals Company Information

10.7.2 Diasome Pharmaceuticals Introduction and Business Overview

10.7.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Diasome Pharmaceuticals Therapeutic Protein Products Offered

10.7.5 Diasome Pharmaceuticals Recent Development

10.8 Eli Lilly

10.8.1 Eli Lilly Company Information

10.8.2 Eli Lilly Introduction and Business Overview

10.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Eli Lilly Therapeutic Protein Products Offered

10.8.5 Eli Lilly Recent Development

10.9 GeneScience Pharmaceuticals

10.9.1 GeneScience Pharmaceuticals Company Information

10.9.2 GeneScience Pharmaceuticals Introduction and Business Overview

10.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.9.4 GeneScience Pharmaceuticals Therapeutic Protein Products Offered

10.9.5 GeneScience Pharmaceuticals Recent Development

10.10 Generex Biotechnology

10.10.1 Generex Biotechnology Company Information

10.10.2 Generex Biotechnology Introduction and Business Overview

10.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.10.4 Generex Biotechnology Therapeutic Protein Products Offered

10.10.5 Generex Biotechnology Recent Development

10.11 Genentech

10.11.1 Genentech Company Information

10.11.2 Genentech Introduction and Business Overview

10.11.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)

10.11.4 Genentech Therapeutic Protein Products Offered

10.11.5 Genentech Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

11.1 Therapeutic Protein Key Raw Materials

11.1.1 Key Raw Materials

11.1.2 Key Raw Materials Price

11.1.3 Raw Materials Key Suppliers

11.2 Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Therapeutic Protein Industrial Chain Analysis

11.4 Therapeutic Protein Market Dynamics

11.4.1 Therapeutic Protein Industry Trends

11.4.2 Therapeutic Protein Market Drivers

11.4.3 Therapeutic Protein Market Challenges

11.4.4 Therapeutic Protein Market Restraints

12 Market Strategy Analysis, Distributors

12.1 Sales Channel

12.2 Therapeutic Protein Distributors

12.3 Therapeutic Protein Downstream Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Chugai Pharmaceutical

Diasome Pharmaceuticals

Eli Lilly

GeneScience Pharmaceuticals

Generex Biotechnology

Genentech Inc

List of Tables

Table 1. Major Company of Monoclonal Antibodies

Table 2. Major Company of Erythropoietin

Table 3. Major Company of Insulin

Table 4. Major Company of Interferon

Table 5. Major Company of Human Growth Hormone

Table 6. Major Company of Follicle Stimulating Hormone

Table 7. Major Company of Blood Clotting Factors

Table 8. Global Therapeutic Protein Sales by Type 2018 VS 2022 VS 2029 (US$ Million)

Table 9. Global Therapeutic Protein Sales by Type (2018-2023) & (K MT)

Table 10. Global Therapeutic Protein Sales Market Share in Volume by Type (2018-2023)

Table 11. Global Therapeutic Protein Sales by Type (2018-2023) & (US& Million)

Table 12. Global Therapeutic Protein Market Share in Value by Type (2018-2023)

Table 13. Global Therapeutic Protein Price by Type (2018-2023) & (USD/MT)

Table 14. Global Therapeutic Protein Sales by Type (2024-2029) & (K MT)

Table 15. Global Therapeutic Protein Sales Market Share in Volume by Type (2024-2029)

Table 16. Global Therapeutic Protein Sales by Type (2024-2029) & (US$ Million)

Table 17. Global Therapeutic Protein Sales Market Share in Value by Type (2024-2029)

Table 18. Global Therapeutic Protein Price by Type (2024-2029) & (USD/MT)

Table 19. North America Therapeutic Protein Sales by Type (2018-2023) & (K MT)

Table 20. North America Therapeutic Protein Sales by Type (2018-2023) & (US$ Million)

Table 21. Europe Therapeutic Protein Sales (K MT) by Type (2018-2023)

Table 22. Europe Therapeutic Protein Sales by Type (2018-2023) & (US$ Million)

Table 23. Asia-Pacific Therapeutic Protein Sales (K MT) by Type (2018-2023)

Table 24. Asia-Pacific Therapeutic Protein Sales by Type (2018-2023) & (US$ Million)

Table 25. Latin America Therapeutic Protein Sales (K MT) by Type (2018-2023)

Table 26. Latin America Therapeutic Protein Sales by Type (2018-2023) & (US$ Million)

Table 27. Middle East and Africa Therapeutic Protein Sales (K MT) by Type (2018-2023)

Table 28. Middle East and Africa Therapeutic Protein Sales by Type (2018-2023) & (US$ Million)

Table 29. Global Therapeutic Protein Sales by Company (2018-2023) & (K MT)

Table 30. Global Therapeutic Protein Sales Share by Company (2018-2023)

Table 31. Global Therapeutic Protein Revenue by Company (2018-2023) & (US$ Million)

Table 32. Global Therapeutic Protein Revenue Share by Company (2018-2023)

Table 33. Global Market Therapeutic Protein Price by Company (2018-2023) & (USD/MT)

Table 34. Global Therapeutic Protein Top Manufacturers Manufacturing Base Distribution and Sales Area

Table 35. Global Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Protein as of 2022)

Table 37. Date of Key Manufacturers Enter into Therapeutic Protein Market

Table 38. Key Manufacturers Therapeutic Protein Product Type

Table 39. Mergers & Acquisitions, Expansion Plans

Table 40. Global Therapeutic Protein Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029

Table 41. Global Therapeutic Protein Sales by Region (2018-2023) & (K MT)

Table 42. Global Therapeutic Protein Sales Market Share in Volume by Region (2018-2023)

Table 43. Global Therapeutic Protein Sales by Region (2018-2023) & (US$ Million)

Table 44. Global Therapeutic Protein Sales Market Share in Value by Region (2018-2023)

Table 45. Global Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 46. Global Therapeutic Protein Sales by Region (2024-2029) & (K MT)

Table 47. Global Therapeutic Protein Sales Market Share in Volume by Region (2024-2029)

Table 48. Global Therapeutic Protein Sales by Region (2024-2029) & (US$ Million)

Table 49. Global Therapeutic Protein Sales Market Share in Value by Region (2024-2029)

Table 50. Global Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)

Table 51. Global Therapeutic Protein Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 52. Global Therapeutic Protein Sales by Application (2018-2023) & (K MT)

Table 53. Global Therapeutic Protein Sales Market Share in Volume by Application (2018-2023)

Table 54. Global Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 55. Global Therapeutic Protein Sales Market Share in Value by Application (2018-2023)

Table 56. Global Therapeutic Protein Price by Application (2018-2023) & (USD/MT)

Table 57. Global Therapeutic Protein Sales by Application (2024-2029) & (K MT)

Table 58. Global Therapeutic Protein Sales Market Share in Volume by Application (2024-2029)

Table 59. Global Therapeutic Protein Sales by Application (2024-2029) & (US$ Million)

Table 60. Global Therapeutic Protein Sales Market Share in Value by Application (2024-2029)

Table 61. Global Therapeutic Protein Price by Application (2024-2029) & (USD/MT)

Table 62. North America Therapeutic Protein Sales by Application (2018-2023) (K MT)

Table 63. North America Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 64. Europe Therapeutic Protein Sales by Application (2018-2023) (K MT)

Table 65. Europe Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 66. Asia-Pacific Therapeutic Protein Sales by Application (2018-2023) (K MT)

Table 67. Asia-Pacific Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 68. Latin America Therapeutic Protein Sales by Application (2018-2023) (K MT)

Table 69. Latin America Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 70. Middle East and Africa Therapeutic Protein Sales by Application (2018-2023) (K MT)

Table 71. Middle East and Africa Therapeutic Protein Sales by Application (2018-2023) & (US$ Million)

Table 72. North America Therapeutic Protein Sales by Country (2018-2023) & (K MT)

Table 73. North America Therapeutic Protein Sales Market Share in Volume by Country (2018-2023)

Table 74. North America Therapeutic Protein Sales by Country (2018-2023) & (US$ Million)

Table 75. North America Therapeutic Protein Sales Market Share in Value by Country (2018-2023)

Table 76. North America Therapeutic Protein Sales by Country (2024-2029) & (K MT)

Table 77. North America Therapeutic Protein Sales Market Share in Volume by Country (2024-2029)

Table 78. North America Therapeutic Protein Sales by Country (2024-2029) & (US$ Million)

Table 79. North America Therapeutic Protein Sales Market Share in Value by Country (2024-2029)

Table 80. Europe Therapeutic Protein Sales by Country (2018-2023) & (K MT)

Table 81. Europe Therapeutic Protein Sales Market Share in Volume by Country (2018-2023)

Table 82. Europe Therapeutic Protein Sales by Country (2018-2023) & (US$ Million)

Table 83. Europe Therapeutic Protein Sales Market Share in Value by Country (2018-2023)

Table 84. Europe Therapeutic Protein Sales by Country (2024-2029) & (K MT)

Table 85. Europe Therapeutic Protein Sales Market Share in Volume by Country (2024-2029)

Table 86. Europe Therapeutic Protein Sales by Country (2024-2029) & (US$ Million)

Table 87. Europe Therapeutic Protein Sales Market Share in Value by Country (2024-2029)

Table 88. Asia-Pacific Therapeutic Protein Sales by Region (2018-2023) & (K MT)

Table 89. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Region (2018-2023)

Table 90. Asia-Pacific Therapeutic Protein Sales by Region (2018-2023) & (US$ Million)

Table 91. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Region (2018-2023)

Table 92. Asia-Pacific Therapeutic Protein Sales by Region (2024-2029) & (K MT)

Table 93. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Region (2024-2029)

Table 94. Asia-Pacific Therapeutic Protein Sales by Region (2024-2029) & (US$ Million)

Table 95. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Region (2024-2029)

Table 96. Latin America Therapeutic Protein Sales by Country (2018-2023) & (K MT)

Table 97. Latin America Therapeutic Protein Sales Market Share in Volume by Country (2018-2023)

Table 98. Latin America Therapeutic Protein Sales by Country (2018-2023) & (US$ Million)

Table 99. Latin America Therapeutic Protein Sales Market Share in Value by Country (2018-2023)

Table 100. Latin America Therapeutic Protein Sales by Country (2024-2029) & (K MT)

Table 101. Latin America Therapeutic Protein Sales Market Share in Volume by Country (2024-2029)

Table 102. Latin America Therapeutic Protein Sales by Country (2024-2029) & (US$ Million)

Table 103. Latin America Therapeutic Protein Sales Market Share in Value by Country (2024-2029)

Table 104. Middle East and Africa Therapeutic Protein Sales by Country (2018-2023) & (K MT)

Table 105. Middle East and Africa Therapeutic Protein Sales Market Share in Volume by Country (2018-2023)

Table 106. Middle East and Africa Therapeutic Protein Sales by Country (2018-2023) & (US$ Million)

Table 107. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Country (2018-2023)

Table 108. Middle East and Africa Therapeutic Protein Sales by Country (2024-2029) & (K MT)

Table 109. Middle East and Africa Therapeutic Protein Sales Market Share in Volume by Country (2024-2029)

Table 110. Middle East and Africa Therapeutic Protein Sales by Country (2024-2029) & (US$ Million)

Table 111. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Country (2024-2029)

Table 112. Amgen Company Information

Table 113. Amgen Introduction and Business Overview

Table 114. Amgen Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 115. Amgen Therapeutic Protein Product

Table 116. Amgen Recent Development

Table 117. Abbott Laboratories Company Information

Table 118. Abbott Laboratories Introduction and Business Overview

Table 119. Abbott Laboratories Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 120. Abbott Laboratories Therapeutic Protein Product

Table 121. Abbott Laboratories Recent Development

Table 122. AstraZeneca Company Information

Table 123. AstraZeneca Introduction and Business Overview

Table 124. AstraZeneca Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 125. AstraZeneca Therapeutic Protein Product

Table 126. AstraZeneca Recent Development

Table 127. Baxter International Company Information

Table 128. Baxter International Introduction and Business Overview

Table 129. Baxter International Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 130. Baxter International Therapeutic Protein Product

Table 131. Baxter International Recent Development

Table 132. Boehringer Ingelheim Company Information

Table 133. Boehringer Ingelheim Introduction and Business Overview

Table 134. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 135. Boehringer Ingelheim Therapeutic Protein Product

Table 136. Boehringer Ingelheim Recent Development

Table 137. Chugai Pharmaceutical Company Information

Table 138. Chugai Pharmaceutical Introduction and Business Overview

Table 139. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 140. Chugai Pharmaceutical Therapeutic Protein Product

Table 141. Chugai Pharmaceutical Recent Development

Table 142. Diasome Pharmaceuticals Company Information

Table 143. Diasome Pharmaceuticals Introduction and Business Overview

Table 144. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 145. Diasome Pharmaceuticals Therapeutic Protein Product

Table 146. Diasome Pharmaceuticals Recent Development

Table 147. Eli Lilly Company Information

Table 148. Eli Lilly Introduction and Business Overview

Table 149. Eli Lilly Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 150. Eli Lilly Therapeutic Protein Product

Table 151. Eli Lilly Recent Development

Table 152. GeneScience Pharmaceuticals Company Information

Table 153. GeneScience Pharmaceuticals Introduction and Business Overview

Table 154. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 155. GeneScience Pharmaceuticals Therapeutic Protein Product

Table 156. GeneScience Pharmaceuticals Recent Development

Table 157. Generex Biotechnology Company Information

Table 158. Generex Biotechnology Introduction and Business Overview

Table 159. Generex Biotechnology Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 160. Generex Biotechnology Therapeutic Protein Product

Table 161. Generex Biotechnology Recent Development

Table 162. Genentech Company Information

Table 163. Genentech Introduction and Business Overview

Table 164. Genentech Therapeutic Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)

Table 165. Genentech Therapeutic Protein Product

Table 166. Genentech Recent Development

Table 167. Key Raw Materials Lists

Table 168. Raw Materials Key Suppliers Lists

Table 169. Therapeutic Protein Market Trends

Table 170. Therapeutic Protein Market Drivers

Table 171. Therapeutic Protein Market Challenges

Table 172. Therapeutic Protein Market Restraints

Table 173. Therapeutic Protein Distributors List

Table 174. Therapeutic Protein Downstream Customers

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Therapeutic Protein Product Picture

Figure 2. Global Therapeutic Protein Market Size, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Therapeutic Protein Market Size Status and Outlook (2018-2029) & (US$ Million)

Figure 4. Global Therapeutic Protein Sales Status and Outlook (2018-2029) & (K MT)

Figure 5. Product Picture of Monoclonal Antibodies

Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2018-2029) & (K MT)

Figure 7. Product Picture of Erythropoietin

Figure 8. Global Erythropoietin Sales YoY Growth (2018-2029) & (K MT)

Figure 9. Product Picture of Insulin

Figure 10. Global Insulin Sales YoY Growth (2018-2029) & (K MT)

Figure 11. Product Picture of Interferon

Figure 12. Global Interferon Sales YoY Growth (2018-2029) & (K MT)

Figure 13. Product Picture of Human Growth Hormone

Figure 14. Global Human Growth Hormone Sales YoY Growth (2018-2029) & (K MT)

Figure 15. Product Picture of Follicle Stimulating Hormone

Figure 16. Global Follicle Stimulating Hormone Sales YoY Growth (2018-2029) & (K MT)

Figure 17. Product Picture of Blood Clotting Factors

Figure 18. Global Blood Clotting Factors Sales YoY Growth (2018-2029) & (K MT)

Figure 19. Global Therapeutic Protein Sales by Type (2018-2029) & (US$ Million)

Figure 20. Global Therapeutic Protein Sales Market Share by Type in 2022 & 2029

Figure 21. North America Therapeutic Protein Sales Market Share in Volume by Type in 2022

Figure 22. North America Therapeutic Protein Sales Market Share in Value by Type in 2022

Figure 23. Europe Therapeutic Protein Sales Market Share in Volume by Type in 2022

Figure 24. Europe Therapeutic Protein Sales Market Share in Value by Type in 2022

Figure 25. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Type in 2022

Figure 26. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Type in 2022

Figure 27. Latin America Therapeutic Protein Sales Market Share in Volume by Type in 2022

Figure 28. Latin America Therapeutic Protein Sales Market Share in Value by Type in 2022

Figure 29. Middle East and Africa Therapeutic Protein Sales Market Share in Volume by Type in 2022

Figure 30. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Type in 2022

Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Protein Sales in 2022

Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Protein Revenue in 2022

Figure 33. Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 34. Product Picture of Pharmaceutical Companies

Figure 35. Global Pharmaceutical Companies Sales YoY Growth (2018-2029) & (K MT)

Figure 36. Product Picture of Healthcare Service Providers

Figure 37. Global Healthcare Service Providers Sales YoY Growth (2018-2029) & (K MT)

Figure 38. Product Picture of Research Organizations

Figure 39. Global Research Organizations Sales YoY Growth (2018-2029) & (K MT)

Figure 40. Product Picture of Academic Research Institutes

Figure 41. Global Academic Research Institutes Sales YoY Growth (2018-2029) & (K MT)

Figure 42. Global Therapeutic Protein Sales by Application (2018-2029) & (US$ Million)

Figure 43. Global Therapeutic Protein Sales Market Share by Application in 2022 & 2029

Figure 44. North America Therapeutic Protein Sales Market Share in Volume by Application in 2022

Figure 45. North America Therapeutic Protein Sales Market Share in Value by Application in 2022

Figure 46. Europe Therapeutic Protein Sales Market Share in Volume by Application in 2022

Figure 47. Europe Therapeutic Protein Sales Market Share in Value by Application in 2022

Figure 48. Asia-Pacific Therapeutic Protein Sales Market Share in Volume by Application in 2022

Figure 49. Asia-Pacific Therapeutic Protein Sales Market Share in Value by Application in 2022

Figure 50. Latin America Therapeutic Protein Sales Market Share in Volume by Application in 2022

Figure 51. Latin America Therapeutic Protein Sales Market Share in Value by Application in 2022

Figure 52. Middle East and Africa Therapeutic Protein Sales Market Share in Value by Application in 2022

Figure 53. Key Raw Materials Price

Figure 54. Therapeutic Protein Manufacturing Cost Structure

Figure 55. Therapeutic Protein Industrial Chain Analysis

Figure 56. Channels of Distribution

Figure 57. Distributors Profiles

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions